Pharmacists are now uniquely positioned to support Canadians at a time when the public health-care system is stretched thin, creating significant barriers for people looking to access care, said Dr. Jennifer Poh, senior director of drug plan solutions at Health Solutions by Shoppers, during Benefits Canada’s 2023 Face to Face Drug Plan Management Forum in […]
With chronic conditions growing in prevalence among plan members, plan sponsors have their work cut out for them in designing benefits plans that provide adequate health support and employee satisfaction while also being cost effective, said Marie-Hélène Dugal, manager of pharmacy benefit strategy for Medavie Blue Cross, during Benefits Canada’s 2023 Face to Face Drug […]
While medications for three interconnected chronic conditions — cardiovascular disease, diabetes and obesity — represent a growing proportion of employers’ drug spend, there’s plenty that can be done to help employees’ slow the progression of these conditions while managing drug plan costs, said Joyce Wong, director of clinical services at Express Scripts Canada, during Benefits […]
As someone who has become increasingly overweight in the last few years, every time I read or write about obesity being referred to as a ‘lifestyle condition’ it makes me physically cringe. Yes, some poor diet choices have contributed to my current physical condition, but it’s much more complex than that. And I know others […]
Obesity has long been misunderstood and stigmatized as a lifestyle condition instead of a complex disease, said Rami Halabi, a medical science liaison with Novo Nordisk, during a webinar hosted by Benefits Canada and sponsored by Novo Nordisk in November. The condition isn’t just a measure of size, but a progressive, relapsing chronic disease characterized […]
The average per-employee cost of U.S. employer-sponsored health benefits has risen by 5.2 per cent in 2023 to reach US$15,797, according to a new survey by Mercer. The survey, which polled more than 1,900 U.S. employers, found cost increases were highest for employers with 50 to 499 employees (7.8 per cent on average) and these […]
While three-quarters (76 per cent) of U.S. employers say they provide coverage of glucagon-like peptide-1 drugs for diabetes management, about a quarter (27 per cent) provide coverage of these drugs for weight loss, according to a new survey by the International Foundation of Employee Benefit Plans. The survey, which polled more than 200 U.S. benefits […]
As the proportion of Canadians living with one or more chronic disease continues to rise, plan sponsors have the opportunity to provide specific solutions to some of the most common conditions in their employee population, said Karen Callaghan, senior director of chronic disease education and patient support at Novo Nordisk, during Benefits Canada‘s 2023 Healthy […]
“We’re now in a very exciting time where we have treatments with previously unseen capacity to improve the control of type 2 diabetes and help our patients manage weight,” said Dr. Sue Pedersen, a specialist in endocrinology and metabolism from Calgary, during a webinar hosted by Benefits Canada and sponsored by Eli Lilly Canada in […]
In 2022, some of the top chronic conditions affecting group benefits plans were diabetes, obesity, depression and arthritis. Diabetes was the No. 1 ranked condition for drug claims in 2022, knocking rheumatoid arthritis down to the No. 2 spot, according to Telus Health’s annual drug plan trends report. And the 2023 Benefits Canada Healthcare Survey […]